Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Eli Lilly and Company
Geert D'Haens; Marla Dubinsky; Taku Kobayashi; Peter M Irving; Stefanie Howaldt; Juris Pokrotnieks; Kathryn Krueger; Janelle Laskowski; Xingyuan Li; Trevor Lissoos; Joe Milata; Nathan Morris; Vipin Arora; Catherine Milch; William Sandborn; Bruce E Sands; LUCENT Study Group